Current funding
German Research Foundation (DFG) - Multi-omics approach including structural variations in the genome of medulloblastoma to detect novel targets
Funding period: 2022-2024
Info: https://gepris-extern.dfg.de/gepris/projekt/497790467
DKTK Joint Funding Projekt LeOPARD - Rapid liquid biopsy and intraoperative diagnostics
Funding period: 2024 - 2026
Info: https://dktk.dkfz.de/en/research/joint-funding-projects/projects/details/62/7375
DKTK Joint Funding Projekt TRUST - Translational program of IT-PD1/NOA-26 study
Funding period: 2024 - 2026
Info: https://dktk.dkfz.de/forschung/joint-funding-programm/projekte/details/58/6751
German Ministry for Education and Research (BMBF) – Reference histology for the GioVax-Trial - A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma
Funding period: 2019 - 2026
Info: Rapp M, Grauer OM, Kamp M, Sevens N, Zotz N, Sabel M, Sorg RV. A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial. Trials. 2018 May 25;19(1):293. doi: 10.1186/s13063-018-2659-7. PubMed
German Cancer Aid - Reference histology for the NOA-28/PRIDE-Trial - Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
Funding period: 2024 - 2026
Info: https://www.journalonko.de/studien/details/pride-nct05871021